Dr Laura Waters

Dr Laura WatersTel: 020 3317 5246
Email: lwaters@nhs.net

Hospital for Tropical Diseases

Tropical and infectious diseases

Professional background

I completed my training in GU medicine in 2007 and then completed a research MD on simplification and switch of antiretroviral therapy. I am currently our hepatitis service and immune in-patient lead. I am on the national antiretroviral guidelines writing committee and organise a number of national and European education, training and teaching events. I am editor of the Journal of n=1 and work with patient groups to develop information materials and thearpy updates.

Research interests

Antiretrovirals, drug toxicity, ageing, issues for women living with HIV, hepatitis C


Waters L et al. Second-line protease inhibitor-based antiretroviral thearpy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backbone. Antivir Ther 2013. 18(2):213-9.

Whitlock GG, Ahmed N, Benn P, Edwards S, Waters L. Stop Routine CD4 Monitoring in HIV-Infected Patients With Fully Suppressed Virus and CD4 >350 Cells/mL. Clin Infect Dis. 2013 Jul;57(2):327-8.

Waters LJ, Barber TJ. Dolutegravir for treatment of HIV: SPRING forwards? Lancet. 2013 Mar 2;381(9868):705-6.

Waters L et al. A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience. Int J STD AIDS. 2012 Aug;23(8):546-52. 

GMC/GDC number: 4552721